See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Presenter: Joshua Loh

October 29, 2013

Presentation TCT 2013

Why I Believe CABG Is (Usually) Better for My Patients

Presenter: Joseph Sabik

October 29, 2013

Presentation TCT 2013

CoreValve US Pivotal Study Design and Extreme Risk Results

Presenter: Steven Yakubov

October 29, 2013

Presentation TCT 2013

Anatomical Effect on Left Atrial After Transcatheter Left Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model

Presenter: Dongming Hou

October 29, 2013

Presentation TCT 2013

My Most Valuable TAVR Lessons: An Interventionalist's Perspective

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

Presenter: Robert Bonow

October 29, 2013

Presentation TCT 2013

The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease

Presenter: Stephan Achenbach

October 29, 2013

Presentation TCT 2013

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Presenter: Byoung Kwon Lee

October 29, 2013

Presentation TCT 2013

TAVR Migration from Inoperable to Moderate Risk Patients: Practice and Caveats

Presenter: Christian Hamm

October 29, 2013

Presentation TCT 2013

TCT-49. Comparison Of Stent Thrombosis Outcomes After Percutaneous Coronary Intervention Across Different Clinical Presentations

Presenter: Joshua Loh

October 29, 2013

Advertisement

Slides

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Why I Believe CABG Is (Usually) Better for My Patients

CoreValve US Pivotal Study Design and Extreme Risk Results

Anatomical Effect on Left Atrial After Transcatheter Left Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model

My Most Valuable TAVR Lessons: An Interventionalist's Perspective

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

TAVR Migration from Inoperable to Moderate Risk Patients: Practice and Caveats

TCT-49. Comparison Of Stent Thrombosis Outcomes After Percutaneous Coronary Intervention Across Different Clinical Presentations

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content